Certolizumab pegol, abatacept, tocilizumab or active conventional treatment in early rheumatoid arthritis: 48-week clinical and radiographic results of the investigator-initiated randomised controlled NORD-STAR trial.
ANNALS OF THE RHEUMATIC DISEASES(2023)
摘要
NCT01491815.
更多查看译文
关键词
Rheumatoid Arthritis, Certolizumab pegol, Abatacept, Methotrexate, Biological Therapy
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要